(Q50202910)

27 February 2018

title

Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study. (English)

1 reference

27 February 2018

0 references

1 reference

Heba R Ghaiad

1

1 reference

27 February 2018

Mohammed M Nooh

series ordinal

2

1 reference

27 February 2018

Maha M El-Sawalhi

series ordinal

3

1 reference

27 February 2018

Amira A Shaheen

series ordinal

4

1 reference

27 February 2018

publication date

11 April 2016

1 reference

27 February 2018

published in

Molecular Neurobiology

1 reference

27 February 2018

volume

54

1 reference

27 February 2018

issue

5

1 reference

27 February 2018

page(s)

3219-3229

1 reference

27 February 2018

https://scigraph.springernature.com/pub.10.1007/s12035-016-9891-5

exact match

0 references

cites work

Promoting remyelination in multiple sclerosis-recent advances

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Cuprizone-induced demyelination as a tool to study remyelination and axonal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Enzymic activities and sodium, potassium and copper concentrations in mouse brain and liver after cuprizone treatment in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Cuprizone treatment induces distinct demyelination, astrocytosis, and microglia cell invasion or proliferation in the mouse cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Mitochondrial sirtuins--a new therapeutic target for repair and protection in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Antioxidants in multiple sclerosis: do they have a role in therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Implications of protease M/neurosin in myelination during experimental demyelination and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Measuring motor coordination in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Differential changes in axonal conduction following CNS demyelination in two mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

The multiple roles of myelin protein genes during the development of the oligodendrocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Aggregation of MBP in chronic demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Regional differences between grey and white matter in cuprizone induced demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Olig1 function is required for oligodendrocyte differentiation in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Oligodendrogenesis in the normal and pathological central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Resveratrol induces mitochondrial biogenesis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

NF-kappa B as a therapeutic target in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Beneficial effects of minocycline on cuprizone induced cortical demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9891-5

NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.

21 January 2018

1 reference

12 December 2020

Myelination and the trophic support of long axons

1 reference

12 December 2020

Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase

1 reference

12 December 2020

Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity

1 reference

12 December 2020

The effects of resveratrol on chronic constriction injury of sciatic nerve in rats

1 reference

12 December 2020

Microsomal lipid peroxidation

1 reference

12 December 2020

Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain

1 reference

12 December 2020

Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord

1 reference

12 December 2020

The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles

1 reference

12 December 2020

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis

1 reference

12 December 2020

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

12 December 2020

Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging

1 reference

12 December 2020

10.1007/S12035-016-9891-5

Identifiers

DOI

1 reference

27 February 2018

PubMed ID

27067589

1 reference

27 February 2018